With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Genomic Alterations in Medulloblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Young Investigator Grants||2008||California|
|Application of Epigenetic Markers for Early Detection of Childhood Leukemia.||University of California San Francisco / Sheng Zhong||Epidemiology Grants||2008||California|
|The TC3 Line, a Zebrafish Model of T-Cell Malignancy||Huntsman Cancer Institute / Nathan Meeker, MD||Young Investigator Grants||2008||Utah|
|Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.||Baylor College of Medicine / Eveline Barbieri, MD, PhD||Young Investigator Grants||2008||Texas|
|Untangling the Matrix in Medulloblastoma||St. Christopher's Hospital for Children / Duncan Stearns, MD||Young Investigator Grants||2008||Ohio|
|Immunotherapeutic Targeting of Stem Cells in Pediatric Brain Tumors||Harbor - UCLA Medical Center / Joseph Lasky||Young Investigator Grants||2008||California|
|Molecular Epidemiology to Detect Tumor Precursors in Children at Risk for Endemic Burkitt's Lymphoma||SUNY Upstate Medical University / Rosemary Rochford||Epidemiology Grants||2008||New York|
|Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.||Huntsman Cancer Institute / Stephen Lessnick||Innovation Grants||2009||Utah|
|Linking mitogenic sonic hedgehog signaling to the oncogene Yap 1 in neural stem/progenitor cells and medulloblastoma.||Memorial Sloan-Kettering Cancer Center / Anna Kenney, PhD||Innovation Grants||2009||New York|
|Pharmacogenomics of childhood AML susceptibility and treatment response.||Children's Hospital of Philadelphia / Richard Aplenc||Innovation Grants||2009||Pennsylvania|